Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Work
Year: 2019
Type: article
Source: The Lancet
Institutions Institut universitaire du cancer de Toulouse Oncopole, Hôpital Cardiologique du Haut-Lévêque, Hôpital Saint-Louis, Centre Hospitalier Universitaire de Tours, Erasmus MC Cancer Institute +46 more
Cites: 32
Cited by: 820
Related to: 10
FWCI: 102.7
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze